HCG: The LH Mimetic With Real Human Evidence
HCG is an FDA-approved LH mimetic with decades of human data — here's what the research actually shows on testicular testosterone, fertility and TRT.
By Research Rats Editorial TeamReviewed by Research Rats Editorial Team
Evidence profile
Assessed 2026-06-18An approved luteinising-hormone mimetic with decades of human data and randomised evidence for maintaining intratesticular testosterone and supporting fertility in hypogonadotropic hypogonadism; the popular off-label TRT-adjunct, symptom-monotherapy and weight-loss uses rest largely on observational data, and dose-related oestrogenic effects, Leydig-cell desensitisation and WADA prohibition for males apply.
Well-established LH/choriogonadotropin-receptor (LHCGR) mechanism: hCG mimics LH on testicular Leydig cells, driving cAMP/PKA steroidogenesis and intratesticular testosterone.
In-vitro and animal work characterises Leydig-cell steroidogenesis, biased agonism versus LH, and a receptor-desensitisation effect with high or chronic stimulation.
Robust for the approved fertility/endocrine indications (a randomised intratesticular-testosterone trial, a 103-study/5,328-patient meta-analysis, an RCT versus clomiphene); the popular TRT-adjunct and symptom-monotherapy uses rest largely on retrospective/observational data with few modern placebo-controlled RCTs.
Meaningful and established for maintaining intratesticular testosterone and supporting fertility in hypogonadotropic hypogonadism, but for sperm production it works best with FSH (hCG alone induces spermatogenesis in only ~40%), and the popular self-directed uses are less well established.
Well-characterised over decades as an approved drug (FDA label, trial and long-term-therapy adverse-event data, clear contraindications).
Approved and long-established as a prescription medicine for selected fertility/endocrine indications.
High for the approved fertility/endocrine indications; lower for the popular off-label TRT-adjunct and monotherapy uses.
An approved prescription hormone, but WADA-prohibited for male athletes, widely used off-label and grey-market, and historically misused in the discredited 'hCG diet'.
Bars show the state of evidence, not desirability. A strong rating on any axis does not mean a compound is safe, effective, or recommended. Human evidence is often limited. Not medical advice.
What to know before reading further
Free for everyone — safety, evidence and regulatory context are never members-only.
Evidence context
An approved placental gonadotropin and luteinising-hormone mimetic with decades of human data and randomised evidence for maintaining intratesticular testosterone and supporting fertility in hypogonadotropic hypogonadism; the popular TRT-adjunct, monotherapy and weight-loss uses rest largely on observational data.
Safety snapshot
A well-characterised prescription hormone; the main constraints are dose-related oestrogenic effects (gynecomastia, water retention), Leydig-cell desensitisation with high or chronic exposure, and limited long-term data for the popular off-label uses.
Regulatory & legality
Approved for specific fertility/endocrine indications but WADA-prohibited for male athletes; the discussed off-label uses fall outside the approval, and grey-market product is not pharmacy-grade.
Where claims can exceed the evidence
Genuinely supported for its approved fertility/endocrine role (with FSH usually needed for sperm production), but body-composition or weight-loss benefit is not established, and the historical 'hCG diet' is unsupported.
This article does not provide dosing, protocol, administration, sourcing, stack, or self-experimentation guidance, or personalised medical advice. It is educational and non-prescriptive — the evidence profile describes the state of research, not an individual decision.
Overview
Most compounds we cover sit on a thin layer of animal data and forum lore. HCG (human chorionic gonadotropin) is the exception. It is a fully FDA-approved drug that has been in human use for decades, and the questions self-experimenters care about — does it keep the testes working on testosterone replacement, does it preserve fertility, does it restore sperm production after a steroid cycle — have been studied in real men, sometimes in randomised trials [1][3].
The short version: hCG behaves like luteinising hormone (LH). It tells the testes to keep making testosterone from the inside, which is precisely the function that exogenous testosterone shuts down. That makes it a genuinely useful tool alongside or instead of TRT. The catch is that the most popular uses — low-dose TRT adjunct, monotherapy for symptoms — rest more on observational data than on modern placebo-controlled trials, and the side effects are real. This is a prescription hormone that wants medical supervision, not a casual grey-market experiment.
Disclaimer. For educational and research purposes only. Not medical advice. We do not sell peptides or compounds.
This detailed research report is available to members
Research Rats is an 18+ educational research platform. Member-only content provides structured evidence interpretation only. It is not medical advice, dosing guidance, protocol guidance, sourcing guidance, cycle design, stack design or treatment advice.
Free safety information remains available where possible.
To continue, create an account or log in and agree to the Terms of Website Use, Privacy Notice, Cookie and Site Technologies Policy, and Medical, Health and Research Disclaimer.
Member access does not provide medical advice, dosing advice, sourcing advice, protocol guidance or treatment recommendations. How Research Rats works
[ Related research ]
HMG (Human Menopausal Gonadotropin): The Original FSH+LH Fertility Drug
HMG is a regulator-approved fertility drug supplying both FSH and LH activity. Strong human evidence, real OHSS risk, and clinician-only use.
Kisspeptin-10: The HPG Axis Master Switch, Explained
Kisspeptin-10 reliably drives LH, FSH and testosterone in human trials, but the libido and fertility headlines mostly come from its longer cousin KP-54.
Oxytocin: The Evidence Behind the "Love Hormone"
Oxytocin's reputation as a trust and bonding hormone outpaces the human evidence — landmark findings failed to replicate and the pivotal autism trial was negative.
PT-141 (Bremelanotide): The Brain-Acting Libido Peptide, Examined
An evidence-first look at PT-141 (bremelanotide): strong phase 3 data in premenopausal women with HSDD, weaker off-label use in men, and real safety trade-offs.